Table 4.
Comparison per year of azole and echinocandin resistance in Candida species isolates tested in the study.
| Year | Antifungal Resistance | Overall | C. albicans | C. Non-albicans |
Candida spp. Excluding C. krusei |
C. parapsilosis Complex | C. glabrata |
|---|---|---|---|---|---|---|---|
| 2020 | Fluconazole % (n) | 11.5 (42/366) | 0.7 (1/150) | 19 (41/216) | 10.7 (39/363) | 22 (31/141) | 15.2 (7/46) |
| Voriconazole % (n) | 4 (14/348) | 3.5 (5/145) | 4.4 (9/204) | 4.1 (14/345) | 5 (7/141) | 5.9 (2/34) | |
| Echinocandin % (n) | 2.6 (8/307) | 0.8 (1/123) | 3.8 (7/184) | 2.3 (7/304) | 0.8 (1/127) | 7.5 (3/40) | |
| 2021 | Fluconazole % (n) | 14.2 (50/351) | 4.5 (8/176) | 24 (42/175) | 11.5 (39/340) | 24.5 (23/94) | 12.2 (6/49) |
| Voriconazole % (n) | 4.5 (15/331) | 3.7 (6/161) | 5.3 (9/170) | 4.6 (15/324) | 8.9 (8/90) | − (0/50) | |
| Echinocandin % (n) | 2.5 (7/278) | − (0/136) | 4.9 (7/142) | 2.6 (7/273) | 5.1 (4/78) | − (0/53) |
Numbers in bold indicate statistically significant difference between 2020 and 2021 (p ≤ 0.05).